Physician profile
David C Ervin
NPI 1306856042
$621.78
in general payments reported to CMS, 2019-2025
13 companies · $78.25 in 2025
The $78.25 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $62.83 · 2021: $93.32 · 2022: $62.00 · 2023: $40.83 · 2024: $103 · 2025: $78.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $202.20 | 2019-2025 | Persona, Tapestry |
| Pacira Therapeutics, INC. | $100.41 | 2019-2020 | |
| Bioventus LLC | $49.30 | 2019-2024 | Durolane |
| Stryker Corporation | $44.50 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $37.48 | 2022-2025 | Exparel |
| Sanofi-Aventis U.S. LLC | $32.35 | 2022-2023 | |
| Lemaitre Vascular, INC. | $31.05 | 2025 | Anastoclip Gc 8cm (Medium) |
| Rock Medical Orthopedics, INC. | $25.00 | 2023 | |
| Ethicon US, LLC | $23.60 | 2024 | Surgicel Nu-Knit |
| Osteomed LLC | $22.36 | 2020 | |
| Depuy Synthes Sales INC. | $18.47 | 2019 | |
| Smith+Nephew, INC. | $17.73 | 2021 | |
| Heron Therapeutics, INC. | $17.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ervin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.